RNA-Seq Transcriptomic Profiling of TGF-β2-Exposed Human Trabecular Meshwork Explants: Advancing Insights Beyond Conventional Cell Culture Models.

RNA-sequencing fibrosis glaucoma trabecular meshwork transforming growth factor-beta 2

Journal

Experimental cell research
ISSN: 1090-2422
Titre abrégé: Exp Cell Res
Pays: United States
ID NLM: 0373226

Informations de publication

Date de publication:
28 Aug 2024
Historique:
received: 25 05 2024
revised: 26 07 2024
accepted: 20 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 30 8 2024
Statut: aheadofprint

Résumé

Primary open-angle glaucoma (POAG), a leading cause of irreversible vision loss, is closely linked to increased intraocular pressure (IOP), with the trabecular meshwork (TM) playing a critical role in its regulation. The TM, located at the iridocorneal angle, acts as a sieve, filtering the aqueous humor from the eye into the collecting ducts, thus maintaining proper IOP levels. The transforming growth factor-beta 2 (TGF-β2) signaling pathway has been implicated in the pathophysiology of primary open-angle glaucoma POAG particularly, in the dysfunction of the TM. This study utilizes human TM explants to closely mimic in vivo conditions, thereby minimizing transcriptional changes that could arise from cell culture enabling an exploration of the transcriptomic impacts of TGF-β2. Through bulk RNA sequencing and immunohistological analysis, we identified distinct gene expression patterns and morphological changes induced by TGF-β2 exposure (5ng/ml for 48 hours). Bulk RNA sequencing identified significant upregulation in genes linked to extracellular matrix (ECM) regulation and fibrotic signaling. Immunohistological analysis further elucidated the morphological alterations, including cytoskeletal rearrangements and ECM deposition, providing a visual confirmation of the transcriptomic data. Notably, the enrichment analysis unveils TGF-β2's influence on both bone morphogenic protein (BMP) and Wnt signaling pathways, suggesting a complex interplay of molecular mechanisms contributing to TM dysfunction in glaucoma. This characterization of the transcriptomic modifications on an explant model of TM obtained under the effect of this profibrotic cytokine involved in glaucoma is crucial in order to develop and test new molecules that can block their signaling pathways.

Identifiants

pubmed: 39214330
pii: S0014-4827(24)00311-2
doi: 10.1016/j.yexcr.2024.114220
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114220

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

Auteurs

J Buffault (J)

Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU Foresight, Paris, France; Department of Ophthalmology, Ambroise Paré Hospital, APHP, Université de Paris Saclay, Boulogne-Billancourt, France. Electronic address: jbuffault@15-20.fr.

É Reboussin (É)

Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France.

F Blond (F)

Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France.

X Guillonneau (X)

Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France.

P Bastelica (P)

Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU Foresight, Paris, France; Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France.

K Kessal (K)

Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France.

M Akkurt Arslan (M)

Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France.

S Melik-Parsadaniantz (S)

Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France.

A Réaux-le Goazigo (A)

Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France.

A Labbé (A)

Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU Foresight, Paris, France; Department of Ophthalmology, Ambroise Paré Hospital, APHP, Université de Paris Saclay, Boulogne-Billancourt, France.

F Brignole-Baudouin (F)

Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France; Department of Biology, CHNO des Quinze-Vingts, IHU Foresight, Paris, France.

C Baudouin (C)

Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU Foresight, Paris, France; Sorbonne Université, INSERM, CNRS, IHU Foresight, Institut de la Vision, Paris, France. Electronic address: cbaudouin@15-20.fr.

Classifications MeSH